MENORA MIVTACHIM HOLDINGS LTD.MENORA MIVTACHIM HOLDINGS LTD.

Institutional investor · Portfolio as of Q2 2023

SEC EDGAR SourceSEC Filings

Top Holdings95 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

2.8M$960.9M8.9%$219.62+49.69%
18 qtrssince 2019-Q1
Increased
62

APPLE INC

4.1M$790.3M7.3%$124.35+53.69%
18 qtrssince 2019-Q1
Decreased
0

ALPHABET INC-CL A

4.8M$579.4M5.4%$98.17+20.41%
18 qtrssince 2019-Q1
Increased
66

APPLIED MATERIALS INC

3.1M$450.4M4.2%$119.54+17.98%
10 qtrssince 2021-Q1
Increased
60

MASTERCARD INC - A

1M$393.5M3.6%$338.18+12.83%
10 qtrssince 2021-Q1
Decreased
0
XLVXLV
ETF

HEALTH CARE SELECT SECTOR SPDR

2.6M$343.6M3.2%$122.35+2.99%
2 qtrssince 2023-Q1
Decreased
0

META PLATFORMS INC-CLASS A

1.1M$321.5M3.0%$258.13+8.31%
13 qtrssince 2020-Q2
Decreased
0

AMAZON.COM INC

2.4M$313.6M2.9%$110.45+15.80%
18 qtrssince 2019-Q1
Increased
53
XLFXLF
ETF

FINANCIAL SELECT SECTOR SPDR

7.4M$248.4M2.3%$30.45+5.58%
2 qtrssince 2023-Q1
Decreased
0
FLKRFLKR
ETF

FRANKLIN TEMPLETON ETF TR

11.1M$239.8M2.2%$18.54+3.15%
2 qtrssince 2023-Q1
Increased
57
XOPXOP
ETF

SPDR SERIES TRUST

1.9M$239.2M2.2%$120.36+0.01%
2 qtrssince 2023-Q1
Increased
85
EMXCEMXC
ETF

ISHARES MSCI EMR MRK EX CHNA

4.5M$233.6M2.2%$46.28+4.34%
2 qtrssince 2023-Q1
Increased
65

WALMART INC

1.5M$229.9M2.1%$40.49+23.42%
18 qtrssince 2019-Q1
Decreased
0

THERMO FISHER SCIENTIFIC INC

420,485$219.4M2.0%$390.43+30.75%
18 qtrssince 2019-Q1
Increased
62

UNITEDHEALTH GROUP INC

430,141$206.7M1.9%$463.75-2.00%
3 qtrssince 2022-Q4
Increased
57
XLPXLP
ETF

CONSUMER STAPLES SPDR

2.7M$201.2M1.9%$68.68-0.07%
2 qtrssince 2023-Q1
Decreased
0

ABBOTT LABORATORIES

1.8M$200.8M1.9%$99.36+2.58%
12 qtrssince 2020-Q3
Increased
58

TESLA INC

766,650$200.7M1.9%$257.500.00%
1 qtr
New
70
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

26.6M$200.1M1.8%$9.28-18.43%
15 qtrssince 2019-Q4
Decreased
0

OTIS WORLDWIDE CORP

2.2M$196.4M1.8%$58.41+43.74%
13 qtrssince 2020-Q2
Decreased
0
$10.8B
AUM
95
Positions
Q2 2023
Filing
Rating · 2.0
Quarterly Portfolio Change
-6%Q1'22$6.9B-21%Q2'22$5.5B-3%Q3'22$5.3B+12%Q4'22$5.9B+63%Q1'23$9.7B+12%Q2'23$10.8B
Activity profile
$ moved · Q2'23
New21%Increased37%Decreased33%Exited8%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.9 years
<1Q12%1-4Q33%1-2Y7%2Y+48%

MENORA MIVTACHIM HOLDINGS LTD. manages $10.8B across 95 positions as of Q2 2023. Top holdings: MSFT (8.9%), AAPL (7.3%), GOOGL (5.4%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q2 2023 Summary

Active quarter - 11 new positions, 9 exits, 24 increased. Top move: XOP (INCREASED, conviction 85). Portfolio: $10.8B across 95 positions.

Top holdings by portfolio weight

Total AUM$11B
MSFT8.88%
AAPL7.30%
GOOGL5.36%
AMAT4.16%
MA3.64%
XLV3.18%
META2.97%
AMZN2.90%
XLF2.30%
FLKR2.22%
Other2.21%

Portfolio allocation by GICS sector

Sectors11
Technology31.95%
Unknown21.65%
Healthcare9.26%
Communication Services8.54%
Consumer Cyclical6.95%
Financial Services5.60%
Industrials4.32%
Basic Materials3.63%
Consumer Defensive3.48%
Energy2.18%
Other2.46%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record52
Conviction45
Concentration62
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
TEVATEVATEVA PHARMACEUTICAL-SP ADR
Q1 2025 Q2 2026+11.5M shares+$724.7M
5Q
KREKRESPDR SERIES TRUST
Q2 2025 Q2 2026+3.3M shares+$248M
4Q
QQQQQQINVESCO QQQ TRUST SERIES 1 CL USD INC
Q3 2025 Q2 2026+10,060 shares+$9.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used